Lupin Limited 15-B, Phase 1A, Verna Industrial Area

Form 483 issued April 7, 2017 · Verna, India

Inspection
Mar 27 – Apr 7, 2017
Observations
1
Pages
8
FEI number
3004819820

In short: On April 7, 2017, FDA issued a Form 483 with 1 observation to Lupin Limited 15-B, Phase 1A, Verna Industrial Area in Verna, India (FEI 3004819820) after an inspection that ran Mar 27 – Apr 7, 2017. The investigators were Andrew J. Idzior and Jogy George. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lupin Limited 15-B, Phase 1A, Verna Industrial Area?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Lupin Limited 15-B, Phase 1A, Verna Industrial Area?

Andrew J. Idzior and Jogy George are named on this Form 483, for the inspection of Mar 27 – Apr 7, 2017. Each investigator has a profile showing what they cite most.

When was Lupin Limited 15-B, Phase 1A, Verna Industrial Area inspected by FDA?

The inspection ran Mar 27 – Apr 7, 2017, and the Form 483 is dated April 7, 2017.

How do I get the full Form 483 for Lupin Limited 15-B, Phase 1A, Verna Industrial Area?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free